Logo image of SUM

Summit Materials Inc (SUM) Stock Fundamental Analysis

NYSE:SUM - New York Stock Exchange, Inc. - US86614U1007 - Common Stock - Currency: USD

52.49  +0.04 (+0.08%)

After market: 52.55 +0.06 (+0.11%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SUM. SUM was compared to 12 industry peers in the Construction Materials industry. SUM has an average financial health and profitability rating. SUM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SUM was profitable.
In the past year SUM had a positive cash flow from operations.
SUM had positive earnings in each of the past 5 years.
SUM had a positive operating cash flow in each of the past 5 years.
SUM Yearly Net Income VS EBIT VS OCF VS FCFSUM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of SUM (1.75%) is worse than 91.67% of its industry peers.
SUM has a Return On Equity of 3.31%. This is amonst the worse of the industry: SUM underperforms 91.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.51%, SUM is doing worse than 91.67% of the companies in the same industry.
SUM had an Average Return On Invested Capital over the past 3 years of 4.89%. This is significantly below the industry average of 10.74%.
Industry RankSector Rank
ROA 1.75%
ROE 3.31%
ROIC 4.51%
ROA(3y)5.18%
ROA(5y)4.04%
ROE(3y)11.46%
ROE(5y)9.43%
ROIC(3y)4.89%
ROIC(5y)4.65%
SUM Yearly ROA, ROE, ROICSUM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 3.92%, SUM is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
SUM's Profit Margin has improved in the last couple of years.
SUM's Operating Margin of 12.64% is on the low side compared to the rest of the industry. SUM is outperformed by 66.67% of its industry peers.
SUM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 29.81%, SUM is in line with its industry, outperforming 58.33% of the companies in the same industry.
SUM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.64%
PM (TTM) 3.92%
GM 29.81%
OM growth 3Y10.44%
OM growth 5Y8.05%
PM growth 3Y22.64%
PM growth 5Y46.57%
GM growth 3Y2.73%
GM growth 5Y-0.58%
SUM Yearly Profit, Operating, Gross MarginsSUM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SUM is destroying value.
Compared to 1 year ago, SUM has more shares outstanding
The number of shares outstanding for SUM has been increased compared to 5 years ago.
The debt/assets ratio for SUM is higher compared to a year ago.
SUM Yearly Shares OutstandingSUM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SUM Yearly Total Debt VS Total AssetsSUM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

SUM has an Altman-Z score of 2.36. This is not the best score and indicates that SUM is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SUM (2.36) is comparable to the rest of the industry.
SUM has a debt to FCF ratio of 16.66. This is a negative value and a sign of low solvency as SUM would need 16.66 years to pay back of all of its debts.
With a Debt to FCF ratio value of 16.66, SUM is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
SUM has a Debt/Equity ratio of 0.63. This is a neutral value indicating SUM is somewhat dependend on debt financing.
SUM's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. SUM is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.66
Altman-Z 2.36
ROIC/WACC0.51
WACC8.78%
SUM Yearly LT Debt VS Equity VS FCFSUM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 3.10 indicates that SUM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.10, SUM belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
SUM has a Quick Ratio of 2.48. This indicates that SUM is financially healthy and has no problem in meeting its short term obligations.
SUM has a better Quick ratio (2.48) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.1
Quick Ratio 2.48
SUM Yearly Current Assets VS Current LiabilitesSUM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

8

3. Growth

3.1 Past

SUM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.27%.
The Earnings Per Share has been growing by 59.94% on average over the past years. This is a very strong growth
SUM shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.48%.
The Revenue has been growing slightly by 4.51% on average over the past years.
EPS 1Y (TTM)1.27%
EPS 3Y24.17%
EPS 5Y59.94%
EPS Q2Q%-7.41%
Revenue 1Y (TTM)49.48%
Revenue growth 3Y3.94%
Revenue growth 5Y4.51%
Sales Q2Q%47.35%

3.2 Future

SUM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.33% yearly.
SUM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.77% yearly.
EPS Next Y10.65%
EPS Next 2Y22.95%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue Next Year64.9%
Revenue Next 2Y33.36%
Revenue Next 3Y24.77%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SUM Yearly Revenue VS EstimatesSUM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
SUM Yearly EPS VS EstimatesSUM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.81, the valuation of SUM can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SUM indicates a slightly more expensive valuation: SUM is more expensive than 75.00% of the companies listed in the same industry.
SUM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.92.
The Price/Forward Earnings ratio is 22.12, which indicates a rather expensive current valuation of SUM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SUM indicates a somewhat cheap valuation: SUM is cheaper than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. SUM is around the same levels.
Industry RankSector Rank
PE 32.81
Fwd PE 22.12
SUM Price Earnings VS Forward Price EarningsSUM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SUM's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, SUM is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 54.44
EV/EBITDA 13.43
SUM Per share dataSUM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SUM's earnings are expected to grow with 25.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.08
PEG (5Y)0.55
EPS Next 2Y22.95%
EPS Next 3Y25.33%

0

5. Dividend

5.1 Amount

SUM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Summit Materials Inc

NYSE:SUM (2/10/2025, 8:24:42 PM)

After market: 52.55 +0.06 (+0.11%)

52.49

+0.04 (+0.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners65.2%
Inst Owner Change-92.77%
Ins OwnersN/A
Ins Owner Change-1.17%
Market Cap9.23B
Analysts70.53
Price Target50.1 (-4.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.89%
Min EPS beat(2)6.65%
Max EPS beat(2)7.13%
EPS beat(4)4
Avg EPS beat(4)19.52%
Min EPS beat(4)6.65%
Max EPS beat(4)48.07%
EPS beat(8)8
Avg EPS beat(8)18.03%
EPS beat(12)10
Avg EPS beat(12)12.07%
EPS beat(16)13
Avg EPS beat(16)13.68%
Revenue beat(2)0
Avg Revenue beat(2)-4.78%
Min Revenue beat(2)-5.63%
Max Revenue beat(2)-3.93%
Revenue beat(4)1
Avg Revenue beat(4)-0.73%
Min Revenue beat(4)-5.63%
Max Revenue beat(4)11.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)2.46%
PT rev (1m)-6.66%
PT rev (3m)-7.35%
EPS NQ rev (1m)1.5%
EPS NQ rev (3m)1.5%
EPS NY rev (1m)1.99%
EPS NY rev (3m)1.99%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 32.81
Fwd PE 22.12
P/S 2.46
P/FCF 54.44
P/OCF 17.11
P/B 2.08
P/tB 4.16
EV/EBITDA 13.43
EPS(TTM)1.6
EY3.05%
EPS(NY)2.37
Fwd EY4.52%
FCF(TTM)0.96
FCFY1.84%
OCF(TTM)3.07
OCFY5.85%
SpS21.36
BVpS25.29
TBVpS12.63
PEG (NY)3.08
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 1.75%
ROE 3.31%
ROCE 6.03%
ROIC 4.51%
ROICexc 4.98%
ROICexgc 7.24%
OM 12.64%
PM (TTM) 3.92%
GM 29.81%
FCFM 4.51%
ROA(3y)5.18%
ROA(5y)4.04%
ROE(3y)11.46%
ROE(5y)9.43%
ROIC(3y)4.89%
ROIC(5y)4.65%
ROICexc(3y)5.44%
ROICexc(5y)5.16%
ROICexgc(3y)8.1%
ROICexgc(5y)7.79%
ROCE(3y)6.53%
ROCE(5y)6.21%
ROICexcg growth 3Y3.53%
ROICexcg growth 5Y5.58%
ROICexc growth 3Y6.61%
ROICexc growth 5Y7.42%
OM growth 3Y10.44%
OM growth 5Y8.05%
PM growth 3Y22.64%
PM growth 5Y46.57%
GM growth 3Y2.73%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.66
Debt/EBITDA 3.33
Cap/Depr 100.52%
Cap/Sales 9.85%
Interest Coverage 3.17
Cash Conversion 64.03%
Profit Quality 115.02%
Current Ratio 3.1
Quick Ratio 2.48
Altman-Z 2.36
F-Score6
WACC8.78%
ROIC/WACC0.51
Cap/Depr(3y)109.47%
Cap/Depr(5y)97.16%
Cap/Sales(3y)9.87%
Cap/Sales(5y)9.04%
Profit Quality(3y)56.33%
Profit Quality(5y)121.42%
High Growth Momentum
Growth
EPS 1Y (TTM)1.27%
EPS 3Y24.17%
EPS 5Y59.94%
EPS Q2Q%-7.41%
EPS Next Y10.65%
EPS Next 2Y22.95%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue 1Y (TTM)49.48%
Revenue growth 3Y3.94%
Revenue growth 5Y4.51%
Sales Q2Q%47.35%
Revenue Next Year64.9%
Revenue Next 2Y33.36%
Revenue Next 3Y24.77%
Revenue Next 5YN/A
EBIT growth 1Y50.79%
EBIT growth 3Y14.79%
EBIT growth 5Y12.92%
EBIT Next Year197.56%
EBIT Next 3Y54.11%
EBIT Next 5YN/A
FCF growth 1Y203.77%
FCF growth 3Y-7.52%
FCF growth 5YN/A
OCF growth 1Y88.16%
OCF growth 3Y2.38%
OCF growth 5Y15.95%